FAQs about VABYSMO
FAQs about VABYSMO
Please note, any and all questions regarding VABYSMO® should be discussed with your retina specialist. These questions may help you get started with the conversation.
VABYSMO is a prescription medicine administered by injection into the eye by your retina specialist.
It is approved for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME).
VABYSMO may cause serious side effects, including:
For people with DME, VABYSMO is given every month for the first 4 or 6 months. Afterwards, your retina specialist will personalize your treatment schedule based on your needs, with the chance to receive as few as 3 injections per year (after 4 or 6 initial monthly doses, receive a minimum of 6 injections over 2 years and a maximum of 21).
Everyone is different, but studies show that VABYSMO may improve your vision after just 1 treatment.
DME is a chronic condition that requires long-term care. Your retina specialist can tell you more about what to expect from treatment with VABYSMO.
Contact your retina specialist right away if you think you might be experiencing any side effects.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
For additional Safety Information, please talk to your retina specialist and see the VABYSMO full Prescribing Information.
If you are already on a vascular endothelial growth factor (VEGF) treatment, ask your retina specialist if switching to VABYSMO is right for you.
There may be options to help you afford your VABYSMO, no matter what type of health insurance you have.
There are a number of things you can do that can make a big difference in the life of a loved one with vision loss associated with DME.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.